Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Complement Tissue injury and its protection during COVID-19

Is Diabetes as dangerous and wicked as COVID-19?

Tata Innovation Fellowship 2020-21 – Life Sciences & Biotechnology

Complement Tissue injury and its protection during COVID-19
  • BiotechToday
  • World

Complement Tissue injury and its protection during COVID-19

bioxone October 7, 2020October 7, 2020

Srilagna Sarkar, Amity University Kolkata

Even though the novel coronavirus disease originates in the lungs, it may extend to other tissues and cause organ damage including cardiac injury, multiorgan failure, and even acute kidney injury, associating it with an increased risk of death. Although the COVID-19 tissue injury is not primarily mediated by any viral infection, it may result in inflammatory host immune response, driving hypercytokinemia and other aggressive inflammation affecting lung parenchymal cell, also diminishing the oxygen rate uptake by the lungs, endothelial cells damage resulting in endothelium and thrombotic evens with intravascular coagulation. 

The complement system signifies the primary responsibility of the host immune system of SARS-COV-2 infection, but several pieces of evidence show there is unstrained activation of complement induced in the lungs and other tissues play a major role in acute and chronic inflammation including thrombus formation, intravascular coagulation, ultimately leading to death due to organ failure.

As protection from tissue injury, besides the efforts on finding an effective antivirus therapy, emphasis on limited tissue injury in severe COVID-19 should be expanded. As, Gonzalez-Nicholas et al – has emphasized, tissue-protective cilastatin against hyper inflammation and its potential to limit virus entry in target cells. However, the fact that COVID-19 patients are frequently with antibiotics may generate early data by conventionally treated COVID-19 patients and will give trials randomizing patients to receive their imipenem – whether cilastatin or some substitute antibiotic. As proof of Cilastatin tissue protection will require testing the compound itself.

Also read: Is Diabetes as dangerous and wicked as COVID-19?

Source: https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfaa196/5917718

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged acute kidney injury cilastatin complement complementation COVID-19 host immunity immunity inflammation response SARS-CoV-2 suppression Tissue injury Tissue injury and COVID-19 Tissue injury and its protection during COVID-19 tissue protection

2 thoughts on “Complement Tissue injury and its protection during COVID-19”

  1. Sohinee roy says:
    October 7, 2020 at 7:27 am

    Nice 👍

    Reply
  2. Barsha Bera says:
    October 10, 2020 at 9:42 am

    Good…. keep it up…. 👌👌👌

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Tata Innovation Fellowship 2020-21 – Life Sciences & Biotechnology

bioxone October 7, 2020

-Shristi Sharma, Team bioXone The details on Tata Innovation Fellowship 2020-21 have been announced. Check the official notification for the Tata Innovation Fellowship 2020-2021 below. DBT India has released the official notification for Tata Innovation Fellowship 2021. Ph.D. Life sciences candidates and MSc Biotechnology candidates eligible to apply for Tata Innovation Fellowship 2021 as per […]

Related Post

  • BiotechToday
  • World

Castration in males delay the ageing of their DNA!

BioTech Today July 11, 2021July 10, 2021

Sayak Banerjee, Amity University Kolkata Hormones vs ageing: Generally, it is observed that men have a shorter life span than women and it has been found that the reason behind this is hormones, but now this could be altered resulting in an increased lifespan. A research team from the Department of Anatomy of the University […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Is COVID-19, a bacterium, or a virus?

bioxone October 18, 2020October 18, 2020

Salapu Chandralekha, Amity University Kolkata What secret did the Italian doctors uncover to prove that the COVID-19 is a bacterium, not a virus as advocated by the WHO guidelines? Italy was one of the European Nation’s which bore the brunt of COVID-19 pandemic accounting for over for 7.2% of deaths recorded across the Globe with […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

The Function of ABCG2 in hyperuricemia and gout

bioxone June 24, 2021June 23, 2021

Madhavi Bhatia,NIPER Guwahati Hyperuricemia is a condition with increased uric acid levels in the blood which results in the deposition of monosodium urate crystals in synovial fluid of joints resulting in gout. Increased levels may be caused due to increased hepatic biosynthesis or reduced renal or intestinal excretion of urate. Most of the urate is […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy